Software Healthcare Sector

BriaCell Therapeutics

Market Cap: CA$48.4m

A pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care.

Cleo Diagnostics

Market Cap: AU$48.7m

A biotechnology company, engages in the development and patent of a blood test for the detection of ovarian cancer in Australia.

Actinium Pharmaceuticals

Market Cap: US$34.6m

Develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies.

MariMed

Market Cap: US$34.6m

Engages in cultivation, production, and selling of branded cannabis products in the United States.

Quince Therapeutics

Market Cap: US$34.5m

A biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases.

Telescope Innovations

Market Cap: CA$47.7m

A chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada.

Reliq Health Technologies

Market Cap: CA$47.3m

A healthcare technology company, develops secure telemedicine and virtual care solutions for the healthcare market.

iTonic Holdings

Market Cap: US$34.1m

A healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy.

Nova Leap Health

Market Cap: CA$47.1m

Provides home-based and community-based healthcare services in the United States and Canada.

Harvard Bioscience

Market Cap: US$34.1m

Develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally.

Arecor Therapeutics

Market Cap: UK£24.9m

A clinical stage biotechnology company, develops therapeutics that address diabetes, obesity and other cardiometabolic diseases in the United Kingdom.

DIAGNOS

Market Cap: CA$47.0m

Provides software-based services for healthcare sector in Canada, the United States, Mexico, and internationally.

Syntara

Market Cap: AU$47.1m

Operates as a clinical-stage drug development company that targets extracellular matrix dysfunction through amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis in Australia.

Lite Strategy

Market Cap: US$33.7m

A clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer.

SkinBioTherapeutics

Market Cap: UK£24.6m

A life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally.

BioNxt Solutions

Market Cap: CA$46.3m

Engages in research, development, manufacture, and sale of next generation drug formulations and delivery systems in Austria, Germany, and Switzerland.

Perimeter Medical Imaging AI

Market Cap: CA$45.3m

A medical technology company, provides advanced imaging solutions to address unmet medical needs.

Rockwell Medical

Market Cap: US$32.6m

Engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide.

Radiopharm Theranostics

Market Cap: AU$45.5m

A clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs.

Accuray

Market Cap: US$32.3m

Engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China.

New Green Hemp

Market Cap: US$32.3m

New Green Hemp Inc. cultivates and sells hemp products.

Greenland Mines

Market Cap: US$32.2m

Engages in the cell and gene therapy, and natural resources businesses.

Neurizon Therapeutics

Market Cap: AU$45.0m

A clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases.

MIRA Pharmaceuticals

Market Cap: US$32.1m

Operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders.

ProText Mobility

Market Cap: US$32.1m

A biotech company, engages in the development of pharmaceutical botanical medicines.

Estrella Immunopharma

Market Cap: US$32.0m

A clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States.

IGC Pharma

Market Cap: US$31.8m

A clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer’s disease in the United States and Colombia.

Mid-Atlantic Home Health Network

Market Cap: US$31.6m

Provides integrated home health products and services for the home health care industry in Virginia, Maryland, and the District of Columbia.

Nexsen

Market Cap: AU$44.0m

Operates as a nanobiotechnology company that develops proprietary biosensing platforms for rapid, high-precision point-of-care (POC) medical diagnostics and point-of-use sensing for veterinary, agricultural, and biosecurity applications.

Sona Nanotech

Market Cap: CA$43.6m

Operates as a nanotechnology life sciences company in the United States and Canada The company researchers and develops gold nanoparticles for potential therapies, including photothermal therapy, tumor targeting activity, anti-bacterial activity, and drug delivery vehicle, as well as diagnostics, such as diagnostic markers for imaging and immunoassay and biosensing.

Doctor Care Anywhere Group

Market Cap: AU$44.0m

Provides digital healthcare and development services in the United Kingdom.

HeraMED

Market Cap: AU$44.0m

A medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States.

Earth Science Tech

Market Cap: US$30.7m

Together with its subsidies, focuses on health and wellness industry.

Actuate Therapeutics

Market Cap: US$30.5m

A clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States.

Modular Medical

Market Cap: US$30.5m

Operates as a medical device company.

Kyntra Bio

Market Cap: US$30.4m

A biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs.